Detailed information for compound 605729

Basic information

Technical information
  • TDR Targets ID: 605729
  • Name: N-butan-2-yl-2-(3-fluorophenyl)-3-(3,4,5-trim ethoxybenzoyl)-1,3-thiazolidine-4-carboxamide
  • MW: 476.561 | Formula: C24H29FN2O5S
  • H donors: 1 H acceptors: 2 LogP: 4.15 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCC(NC(=O)C1CSC(N1C(=O)c1cc(OC)c(c(c1)OC)OC)c1cccc(c1)F)C
  • InChi: 1S/C24H29FN2O5S/c1-6-14(2)26-22(28)18-13-33-24(15-8-7-9-17(25)10-15)27(18)23(29)16-11-19(30-3)21(32-5)20(12-16)31-4/h7-12,14,18,24H,6,13H2,1-5H3,(H,26,28)
  • InChiKey: QKMIKDMANNWRNY-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-(3-fluorophenyl)-N-sec-butyl-3-(3,4,5-trimethoxybenzoyl)thiazolidine-4-carboxamide
  • 2-(3-fluorophenyl)-3-[oxo-(3,4,5-trimethoxyphenyl)methyl]-N-sec-butyl-4-thiazolidinecarboxamide
  • N-butan-2-yl-2-(3-fluorophenyl)-3-(3,4,5-trimethoxyphenyl)carbonyl-1,3-thiazolidine-4-carboxamide

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.152663 0.78013 0.78013
Loa Loa (eye worm) hypothetical protein 0.152663 0.78013 0.78013
Schistosoma mansoni serine/threonine protein kinase 0.130035 0.61824 1
Loa Loa (eye worm) hypothetical protein 0.174393 0.935587 0.935587
Schistosoma mansoni serine/threonine protein kinase 0.0973211 0.384201 0.578282
Echinococcus multilocularis serine threonine protein kinase 0.0755916 0.228744 0.369992
Echinococcus granulosus protein kinase c epsilon type 0.130035 0.61824 1
Loa Loa (eye worm) AGC/PKC/ALPHA protein kinase 0.0455215 0.0136171 0.0136171
Echinococcus multilocularis protein kinase c epsilon type 0.130035 0.61824 1
Loa Loa (eye worm) hypothetical protein 0.0653476 0.155457 0.155457
Echinococcus multilocularis serine:threonine protein kinase N2 0.107065 0.453909 0.734195
Entamoeba histolytica PH domain containing protein kinase, putative 0.0769947 0.238782 0.5
Echinococcus granulosus protein kinase c iota type 0.0524625 0.0632742 0.102346
Loa Loa (eye worm) hypothetical protein 0.152663 0.78013 0.78013
Onchocerca volvulus 0.152663 0.78013 0.5
Brugia malayi protein kinase C II. 0.130035 0.61824 1
Echinococcus granulosus protein kinase C gamma type 0.0755916 0.228744 0.369992
Echinococcus granulosus serine:threonine protein kinase N2 0.0769947 0.238782 0.386229
Loa Loa (eye worm) hypothetical protein 0.183397 1 1
Echinococcus granulosus Protein kinase C brain isozyme 0.0973211 0.384201 0.621443
Echinococcus multilocularis Protein kinase C, brain isozyme 0.0973211 0.384201 0.621443
Schistosoma mansoni serine/threonine protein kinase 0.0973211 0.384201 0.578282
Loa Loa (eye worm) AGC/PKC/ETA protein kinase 0.130035 0.61824 0.61824
Echinococcus multilocularis protein kinase c iota type 0.0524625 0.0632742 0.102346

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence. ChEMBL. 22096101
CC50 (functional) > 0.654 uM Huh7 cytotoxicity for Pf inhibitors Novartis-GNF Malaria Box. No reference
CC50 > 0.654 uM NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) ChEMBL. 18579783
EC50 (functional) = 0.02984 uM W2 Pf proliferation inhibition Novartis-GNF Malaria Box. No reference
EC50 (functional) = 0.02984 uM NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay ChEMBL. 18579783
EC50 (functional) > 1.25 uM PF proliferation inhibition 3D7 Novartis-GNF Malaria Box. No reference
EC50 (functional) > 1.25 uM NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ChEMBL. 18579783
IFI promiscuity index = 0.01923 IFI promiscuity index Novartis-GNF Malaria Box. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23 18579783

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.